Selective targeting of signet ring cell adenocarcinomas
dc.authorid | Abdullah Olgun / 0000-0002-6976-9286 | en_US |
dc.authorscopusid | Abdullah Olgun / 6603877209 | |
dc.authorwosid | Abdullah Olgun / FPP-8980-2022 | |
dc.contributor.author | Olgun, Abdullah | |
dc.date.accessioned | 2020-08-30T20:06:25Z | |
dc.date.available | 2020-08-30T20:06:25Z | |
dc.date.issued | 2019 | |
dc.department | İstinye Üniversitesi, Eczacılık Fakültesi, Eczacılık Temel Bilimleri Bölümü | en_US |
dc.description.abstract | Many epithelial tumors, especially signet-ring cell adenocarcinomas, produce huge amounts of mucin glycoproteins that fill cytoplasm and push nucleus to the periphery, giving a signet ring like structure to the cell. Mucin proteins are very rich of l-threonine which is essential in humans. L-threonine content can reach up to 35% of total amino acid composition of some mucin proteins. Therefore l-threonine can be the Achilles heel of signet ring cell adenocarcinomas which are one of the most malignant and agressive cancers. A modified bioisoster of l-threonine, 4-fluoro l-threonine (its fluorine can be radioactive or not), can be used to selectively kill signet ring cancer cells without harming normal cells or for diagnostic purposes. | en_US |
dc.identifier.citation | Olgun, A. (2019). Selective targeting of signet ring cell adenocarcinomas. MEDICAL HYPOTHESES, 133. https://doi.org/10.1016/j.mehy.2019.109380 | en_US |
dc.identifier.doi | 10.1016/j.mehy.2019.109380 | en_US |
dc.identifier.issn | 0306-9877 | en_US |
dc.identifier.issn | 1532-2777 | en_US |
dc.identifier.pmid | 31454636 | en_US |
dc.identifier.scopus | 2-s2.0-85071099394 | en_US |
dc.identifier.scopusquality | Q2 | en_US |
dc.identifier.uri | https://doi.org/10.1016/j.mehy.2019.109380 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12713/512 | |
dc.identifier.volume | 133 | en_US |
dc.identifier.wos | WOS:000500360500001 | en_US |
dc.identifier.wosquality | Q4 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.institutionauthor | Olgun, Abdullah | en_US |
dc.language.iso | en | en_US |
dc.publisher | Churchill Livingstone | en_US |
dc.relation.ispartof | Medical Hypotheses | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Signet-Ring Cell Cancer | en_US |
dc.subject | Mucin Proteins | en_US |
dc.subject | 4-Fluoro L-Threonine | en_US |
dc.subject | Systemic Radiotherapy | en_US |
dc.title | Selective targeting of signet ring cell adenocarcinomas | en_US |
dc.type | Article | en_US |
dcterms.description |
Dosyalar
Orijinal paket
1 - 1 / 1
Küçük Resim Yok
- İsim:
- 258.pdf
- Boyut:
- 160.46 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama:
- Tam Metin / Full Text